Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 14, 2021 - Issue 10
Submit an article Journal homepage
3,557
Views
8
CrossRef citations to date
0
Altmetric
Letter to the Editor

Who is blind in psychedelic research? Letter to the editor regarding: blinding and expectancy confounds in psychedelic randomized controlled trials

Eduardo Ekman SchenbergDirector, Instituto Phaneros, São Paulo, BrazilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7111-9891View further author information
ORCID Icon
Pages 1317-1319 | Published online: 17 Aug 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Suresh D Muthukumaraswamy. (2023) Overcoming blinding confounds in psychedelic randomized controlled trials using biomarker driven causal mediation analysis. Expert Review of Clinical Pharmacology 16:12, pages 1163-1173.
Read now
Lynnette A. Averill & Chadi G. Abdallah. (2022) Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine. Expert Opinion on Investigational Drugs 31:2, pages 133-137.
Read now

Articles from other publishers (6)

Jordan Sloshower, Patrick D. Skosnik, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful Syed, Brian Pittman & Deepak Cyril D’Souza. (2023) Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial. Journal of Psychopharmacology, pages 026988112311548.
Crossref
Eduardo Ekman Schenberg & Konstantin Gerber. (2022) Epistemic losses, cultural exclusions, and the risk of biopiracy in the globalization of ayahuasca: A reply to Labate et al.. Transcultural Psychiatry 59:5, pages 714-717.
Crossref
Matt Butler, Luke Jelen & James Rucker. (2022) Expectancy in placebo-controlled trials of psychedelics: if so, so what?. Psychopharmacology 239:10, pages 3047-3055.
Crossref
Camila Sanz, Federico Cavanna, Stephanie Muller, Laura de la Fuente, Federico Zamberlan, Matías Palmucci, Lucie Janeckova, Martin Kuchar, Facundo Carrillo, Adolfo M. García, Carla Pallavicini & Enzo Tagliazucchi. (2022) Natural language signatures of psilocybin microdosing. Psychopharmacology 239:9, pages 2841-2852.
Crossref
Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P. C. Kuypers & Zach Walsh. (2022) Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls. Scientific Reports 12:1.
Crossref
Jacob S. Aday, Boris D. Heifets, Steven D. Pratscher, Ellen Bradley, Raymond Rosen & Joshua D. Woolley. (2022) Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials. Psychopharmacology 239:6, pages 1989-2010.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.